Monday, November 01, 2010

atypical antipsychotics (AAPs) increases the risk of significant weight gain

More research appears to confirm recent results of a large, prospective cohort study that the use of atypical antipsychotics (AAPs) increases the risk of significant weight gain and varied metabolic changes in children and adolescents with mental illness and behavioral disturbances. According to Dr. Panagiotopoulos, a growing body of evidence in adults demonstrating that AAPs cause significant weight gain, hyperlipidemia, and insulin resistance has raised concerns among the medical community in general, and the psychiatric community in particular, about whether these drugs may increase the risk of premature cardiovascular disease in children and adolescents. [http://www.medscape.com/viewarticle/712079]

 

No comments: